Double maintains 3 strategies that include BLFS - BioLife Solutions, Inc.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
GNOM | 62.76% | $44.34M | 0.5% |
ARKG | 62.18% | $980.60M | 0.75% |
XHE | 59.39% | $178.99M | 0.35% |
IWC | 59.04% | $813.58M | 0.6% |
IWO | 59.01% | $11.46B | 0.24% |
XBI | 58.39% | $4.89B | 0.35% |
VTWO | 58.30% | $12.36B | 0.07% |
KJAN | 58.25% | $288.29M | 0.79% |
IWM | 58.21% | $62.41B | 0.19% |
KJUL | 58.19% | $119.80M | 0.79% |
GSSC | 57.41% | $551.51M | 0.2% |
PBE | 57.39% | $229.19M | 0.58% |
PRFZ | 57.18% | $2.36B | 0.34% |
USVM | 57.18% | $922.19M | 0.3% |
SCHA | 57.09% | $17.13B | 0.04% |
ISCG | 57.01% | $673.24M | 0.06% |
NUSC | 56.87% | $1.14B | 0.31% |
CPRJ | 56.54% | $47.74M | 0.69% |
VIOO | 56.41% | $2.88B | 0.1% |
ESML | 56.32% | $1.82B | 0.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHM | -0.06% | $3.39B | 0.2% |
JUCY | 0.09% | $273.98M | 0.6% |
CGCB | 0.10% | $2.32B | 0.27% |
JBND | -0.23% | $2.13B | 0.25% |
PWZ | -0.24% | $702.78M | 0.28% |
CORN | -0.28% | $47.42M | 0.2% |
UUP | 0.30% | $209.44M | 0.77% |
VTEB | -0.33% | $36.04B | 0.03% |
SHAG | 0.34% | $38.00M | 0.12% |
AGZD | -0.35% | $110.64M | 0.23% |
JMUB | 0.38% | $2.92B | 0.18% |
TDTF | 0.40% | $810.82M | 0.18% |
IBMP | -0.43% | $541.08M | 0.18% |
TAXF | -0.58% | $493.06M | 0.29% |
FXE | 0.61% | $547.46M | 0.4% |
MMIN | 0.68% | $479.55M | 0.3% |
CGMU | -0.76% | $3.27B | 0.27% |
GOVI | 0.76% | $891.71M | 0.15% |
BSMR | -0.78% | $255.06M | 0.18% |
ISTB | 0.80% | $4.41B | 0.06% |
Yahoo
The average of price targets set by Wall Street analysts indicates a potential upside of 41.7% in BioLife Solutions (BLFS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Yahoo
On May 27, H.C. Wainwright reaffirmed its Buy rating on BioLife Solutions, Inc. (NASDAQ:BLFS) while keeping the price target the same at $30. The bullish sentiment comes after the firm adjusted its financial model for the company. The company released its fiscal first quarter results for 2025. It delivered a revenue of $23.9 million, up […]
Yahoo
Biolife's haemostatic devices are manufactured under the StatSeal and WoundSeal brand names.
Yahoo
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the company will be participating in the following investor conferences:
Yahoo
The consensus price target hints at a 30.7% upside potential for BioLife Solutions (BLFS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Yahoo
BioLife Solutions ( NASDAQ:BLFS ) First Quarter 2025 Results Key Financial Results Revenue: US$23.9m (down 11% from 1Q...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -22.69% | $23.34B | +31.58% | 1.12% |
LITB | -12.12% | $21.77M | -74.81% | 0.00% |
KMB | -10.89% | $44.08B | -1.73% | 3.72% |
ED | -10.13% | $36.95B | +12.52% | 3.26% |
CME | -10.04% | $97.17B | +37.77% | 3.95% |
FMTO | -9.85% | $5.10K | -99.92% | 0.00% |
EXC | -8.40% | $43.29B | +23.40% | 3.60% |
STG | -8.07% | $32.24M | -0.16% | 0.00% |
DG | -7.53% | $24.53B | -10.79% | 2.13% |
AQB | -7.34% | $3.52M | -50.00% | 0.00% |
PULM | -7.32% | $30.39M | +340.19% | 0.00% |
MO | -7.19% | $100.92B | +30.61% | 6.82% |
AWK | -6.93% | $27.42B | +9.74% | 2.22% |
TEF | -6.06% | $29.51B | +15.71% | 5.96% |
DUK | -5.71% | $90.43B | +14.83% | 3.58% |
ASPS | -5.23% | $90.06M | -41.81% | 0.00% |
CORT | -5.03% | $7.55B | +118.26% | 0.00% |
FTS | -4.81% | $23.79B | +20.36% | 3.66% |
AEP | -4.65% | $54.46B | +15.89% | 3.59% |
SO | -4.09% | $98.42B | +14.16% | 3.23% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PM | 0.43% | $285.42B | +78.64% | 2.93% |
PG | -0.49% | $380.07B | -1.86% | 2.51% |
T | 0.51% | $203.92B | +60.93% | 3.93% |
MSIF | 0.51% | $831.23M | +47.01% | 6.11% |
SAVA | 0.55% | $100.96M | -89.04% | 0.00% |
SYPR | -0.60% | $44.35M | +2.66% | 0.00% |
PHYS | 0.87% | - | - | 0.00% |
MCK | -1.10% | $89.80B | +22.74% | 0.39% |
JNJ | 1.13% | $373.57B | +6.77% | 3.23% |
DRD | 1.14% | $1.21B | +68.55% | 1.94% |
COR | 1.16% | $55.56B | +24.55% | 0.74% |
GFI | 1.27% | $21.79B | +53.72% | 2.21% |
BCE | 1.34% | $20.69B | -34.53% | 12.44% |
AIFU | -1.43% | $3.36B | 0.00% | 0.00% |
ZCMD | 1.45% | $26.26M | -13.33% | 0.00% |
VZ | -1.66% | $184.42B | +9.98% | 6.26% |
BTI | -1.76% | $106.86B | +59.05% | 6.30% |
UUU | 1.79% | $7.36M | +96.30% | 0.00% |
CCI | 1.84% | $43.30B | -0.24% | 6.28% |
UL | 1.85% | $154.49B | +12.27% | 3.06% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -40.85% | $153.01M | 0.85% |
BTAL | -40.32% | $298.87M | 1.43% |
TAIL | -39.80% | $107.77M | 0.59% |
IVOL | -24.89% | $358.39M | 1.02% |
FTSD | -17.17% | $228.13M | 0.25% |
SPTS | -16.76% | $5.78B | 0.03% |
XONE | -15.92% | $634.70M | 0.03% |
SHYM | -15.46% | $324.05M | 0.35% |
FXY | -15.03% | $857.17M | 0.4% |
VGSH | -14.69% | $22.40B | 0.03% |
UTWO | -14.63% | $374.41M | 0.15% |
LDUR | -14.08% | $913.73M | 0.5% |
ULST | -13.99% | $663.99M | 0.2% |
SCHO | -13.89% | $10.93B | 0.03% |
STPZ | -13.20% | $451.45M | 0.2% |
IBTG | -12.38% | $1.94B | 0.07% |
IBMN | -11.94% | $447.67M | 0.18% |
BSMW | -11.66% | $102.07M | 0.18% |
FTSM | -11.54% | $6.46B | 0.45% |
IBTH | -11.34% | $1.57B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RGEN | 56.42% | $7.42B | -7.61% | 0.00% |
BEAM | 55.65% | $1.80B | -31.35% | 0.00% |
KN | 52.58% | $1.53B | -2.39% | 0.00% |
DXC | 52.38% | $2.91B | -15.55% | 0.00% |
TXG | 51.70% | $1.35B | -49.51% | 0.00% |
DIOD | 50.80% | $2.36B | -32.21% | 0.00% |
TECH | 50.25% | $8.08B | -33.45% | 0.62% |
RVTY | 50.13% | $11.32B | -14.64% | 0.29% |
DHR | 50.06% | $146.51B | -22.63% | 0.55% |
AZTA | 49.40% | $1.41B | -45.19% | 0.00% |
A | 49.28% | $34.01B | -10.09% | 0.81% |
SITE | 48.88% | $5.54B | -8.05% | 0.00% |
CTS | 48.69% | $1.27B | -18.30% | 0.38% |
KEYS | 48.34% | $27.97B | +17.66% | 0.00% |
PX | 48.20% | $1.11B | +22.30% | 1.46% |
BCO | 48.04% | $3.55B | -16.21% | 1.17% |
ACA | 47.77% | $4.36B | +5.11% | 0.23% |
DOCN | 47.50% | $2.63B | -25.59% | 0.00% |
NOVT | 47.44% | $4.60B | -22.47% | 0.00% |
CYRX | 47.41% | $346.45M | -34.75% | 0.00% |
Current Value
$23.591 Year Return
Current Value
$23.591 Year Return